What the combination doesn't do: accelerate initial appetite suppression (that's entirely GLP-1-driven), reduce gastrointestinal side effects from semaglutide (nausea, vomiting, diarrhea still occur at the same frequency), or eliminate the need for protein intake above 1.6 g/kg body weight daily
Long-term use of semaglutide for weight loss Semaglutide, like other GLP-1 medications, is designed to be taken long-term
Discussing with your healthcare provider in Concord about medications aligned with FDA approval for weight management, such as Wegovy or Zepbound, can better align with your needs and ease insurance validation
AT has received honoraria from Amgen, Boehringer Ingelheim Japan, Mochida, and Novo Nordisk, as well as research funding from Bristol-Myers Squibb, GlaxoSmithKline, and Novo Nordisk
Treatment is taken as a once-weekly injection or oral option, depending on what your provider recommends